| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442556 | European Journal of Cancer | 2015 | 10 Pages |
Abstract
The overall outcome for patients with GBM remains poor. However, aggressive treatment at every age group is associated with extended survival similar to that described in clinical trials.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrew Brodbelt, David Greenberg, Tim Winters, Matt Williams, Sally Vernon, V. Peter Collins, (UK) National Cancer Information Network Brain Tumour Group (UK) National Cancer Information Network Brain Tumour Group,